Antares Pharma (ATRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 56,201 | 4,815 | -181 | -2,356 | -2,027 |
| Depreciation Amortization | 2,627 | 1,730 | 1,132 | 570 | 2,557 |
| Income taxes - deferred | -47,203 | N/A | N/A | N/A | -371 |
| Accounts receivable | -7,128 | -7,422 | 785 | 3,663 | -16,095 |
| Accounts payable and accrued liabilities | 2,594 | 5,171 | 3,680 | 5,479 | 926 |
| Other Working Capital | 690 | 1,241 | 3,826 | 5,244 | -17,986 |
| Other Operating Activity | 13,539 | 8,682 | 19 | -7,020 | 22,381 |
| Operating Cash Flow | $21,320 | $14,217 | $9,261 | $5,580 | $-10,615 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 22,500 | 20,500 | 14,500 | 6,000 | N/A |
| PPE Investments | -9,333 | -7,893 | -2,444 | -641 | 2,650 |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -22,645 |
| Purchase Sale Intangibles | -5,000 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -5,000 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $8,167 | $12,607 | $12,056 | $5,359 | $-19,995 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 15,000 |
| Common Stock Issued | 1,814 | 1,512 | 389 | 271 | 12,186 |
| Other Financing Activity | -1,367 | -1,366 | -1,350 | -597 | -1,267 |
| Financing Cash Flow | $447 | $146 | $-961 | $-326 | $25,919 |
| Exchange Rate Effect | 2 | 1 | 1 | N/A | N/A |
| Beginning Cash Position | 23,201 | 23,201 | 23,201 | 23,201 | 27,892 |
| End Cash Position | 53,137 | 50,172 | 43,558 | 33,814 | 23,201 |
| Net Cash Flow | $29,936 | $26,971 | $20,357 | $10,613 | $-4,691 |
| Free Cash Flow | |||||
| Operating Cash Flow | 21,320 | 14,217 | 9,261 | 5,580 | -10,615 |
| Capital Expenditure | -9,615 | -7,893 | -2,444 | -641 | -2,350 |
| Free Cash Flow | 11,705 | 6,324 | 6,817 | 4,939 | -12,965 |